Jana Vree

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Childhood Cancer

Top Venues

Cancer immunology research

Leiden University Medical Center

Avans University of Applied Sciences (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center

Netherlands

Research technician :: Department of Immunology

VU University Medical Center

Netherlands

Research Technician :: Medical Oncology

VU University Medical Center

Netherlands

Research technician :: Medical Oncology/ MCBI

Education History

Avans University of Applied Sciences

Netherlands

BSC

Publications

Elena Tondini, Niels R M Reintjens, Giulia Castello, Tsolere Arakelian, Marjolein Isendoorn, Marcel Camps, Jana Vree, Gijs A van der Marel, Dmitri V Filippov, Jeroen D C Codee, Ferry Ossendorp
Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control. NPJ vaccines 7 (1) (2022)
Roeland Lameris, Adam Shahine, Daniel G Pellicci, Adam P Uldrich, Stephanie Gras, Jérôme Le Nours, Richard W J Groen, Jana Vree, Scott J J Reddiex, Sergio M Quiñones-Parra, Stewart K Richardson, Amy R Howell, Sonja Zweegman, Dale I Godfrey, Tanja D de Gruijl, Jamie Rossjohn, Hans J van der Vliet
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response. Nature cancer 1 (11) (2020)
Iris de Weerdt, Roeland Lameris, George L Scheffer, Jana Vree, Renate de Boer, Anita G Stam, Rieneke van de Ven, Mark-David Levin, Steven T Pals, Rob C Roovers, Paul W H I Parren, Tanja D de Gruijl, Arnon P Kater, Hans J van der Vliet
A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies. Cancer immunology research 9 (1) (2020)